Groupe Hospitalier Saint André - Hôpital Saint André

Bordeaux, Gironde 33075

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Pancreatic Adenocarcinoma, UC (Urothelial Cancer)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201) — Completed
• Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) — Completed